DoR Communicator - November 2013 by Division of Research, Florida International University
Florida International University
FIU Digital Commons
Office of Research and Economic Development
Newsletters Office of Research and Economic Development
11-2013
DoR Communicator - November 2013
Division of Research, Florida International University
Follow this and additional works at: http://digitalcommons.fiu.edu/research_newsletter
This work is brought to you for free and open access by the Office of Research and Economic Development at FIU Digital Commons. It has been
accepted for inclusion in Office of Research and Economic Development Newsletters by an authorized administrator of FIU Digital Commons. For
more information, please contact dcc@fiu.edu.
Recommended Citation
Division of Research, Florida International University, "DoR Communicator - November 2013" (2013). Office of Research and
Economic Development Newsletters. Book 5.
http://digitalcommons.fiu.edu/research_newsletter/5
Researchers exchange ideas and meet prospective collaborators 
By Robyn Nissim 
November 2013 Issue 
With more than 400 funded research-
ers spread across two campuses and 
three centers, including FIU Down-
town on Brickell and the Miami Beach 
Urban Studios, it can be difficult to 
learn about the university's research 
efforts—even those that are in one's 
particular specialty. But one of DoR's 
top priorities in the next few years is 
to build interdisciplinary research and 
to promote integration and support 
integration of ideas. The best way to 
accomplish this initiative is to intro-
duce the researchers to each other and 
let them form new relationships within 
and without their areas of interest.  
On October 18, FIU scholars and re-
searchers met with the vice president 
for research, Andrés G. Gil, and senior 
leadership within DoR to exchange 
ideas on increasing research funding 
as well as meet prospective collabora-
tors. It was a unique opportunity for 
the faculty to network with their peers 
in a non-academic setting. There are 
so many talented research faculty at 
FIU that the event will be held again at 
a later date to accommodate more re-
searchers.  
Assistant professor of psychology Lind-
say Malloy was happy to meet faculty 
outside her department to discuss possi-
ble collaborations. “The DoR reception 
was an excellent opportunity to chat 
with faculty outside my department, to 
learn about the exciting research that 
they are working on currently, and to 
find out about how they funded it,” said 
Malloy.  Additionally, she was able to 
find others who can guide her—“as 
soon as I mentioned an interest in apply-
ing for a NSF Career proposal, I was 
immediately introduced to someone 
who had received one in the past and 
others who had great advice on prepar-
ing one! This was a very valuable op-
portunity, and I appreciated the chance 
to spend an afternoon getting to know so 
many accomplished people who were 
willing to share their experiences and 
advice.” Malloy is currently study-
ing theoretical and practical questions 
concerning children’s disclosure of neg-
ative experiences and children’s in-
volvement in the legal system.  
But after this event, look for Malloy to 
be an investigator on other  studies— 
maybe even as an awardee on an NSF 
Career proposal.  
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Luis Salas, associate vice president for research, 
discusses research development and funding 
opportunities with Lindsay Malloy, assistant 
professor of psychology 
From left to right, Leonard Scinto (assistant professor, 
SEAS), Andrés Gil (vice president for research), and 
Fernando Noriega (professor, biology) 
For updates, corrections, suggestions, and/or general comments, please email Mercedes.rodriguez@fiu.edu 
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Upcoming Events 
 
November 2013 
 November 1 at 9 am in EC 2300, “Ink-Jet Printing of Sol-Gel Derived Bioinks to Produce Bioactive Paper Sensors 
for Environmental and Biomedical Analysis” by John D. Brennan from McMaster University, Ontario, Canada—part 
of the Wallace H. Coulter Foundation BME Seminar Series.  
 November 1 at 12 noon in AHC1 # 110 “The Impact of Social Withdrawal on Children’s Adjustment: Physiological 
and Contextual Influences” by Heather Henderson—part of CCF’s Brown Bag Series. 
 November 3 through 5: Society for the Study of Human Development 8th Biennial Meeting at Westin Beach Hotel 
and Spa: “Rethinking Developmental Science across the Life-span/Life-course: Theory, Methods and Applications.” 
http://sish.fiu.edu/events/2013/fort-lauderdale-society-for-the-study-of-human-development-conference/  
 November 7 from 10 am to 12 noon in RDB 1000, the Center for Leadership presents Robert Schreiter.  Please visit 
http://lead.fiu.edu/engagement/lectureseries/leadership/index.html for registration details. 
 November 8 at 9 am in EC 2300, “Coupled Multiscale Analysis of Bio and Nano–Mechanical Systems” by Vinu 
Unnikrishnan from the University of Alabama—part of the Wallace H. Coulter Foundation BME Seminar Series.  
 November 8 at 12 noon in ACH1 #110 “Extending the Scope and Accessibility of Children’s Mental Health Care 
through Technology” by Jon Comer—part of CCF’s Brown Bag Series. 
 November 12 at 10 am Ribbon Cutting Ceremony, Stocker AstroScience Center (President Emeritus Modesto 
Maidique, Dean Ken Furton, and Special Guest Nobel laureate John Mather, with James Webb as emcee). Reception 
to follow at 11 am. 
 November 12 from 3:30 to 4:45 pm in AHC3 #110, “The History of the Universe from Beginning to End, and 
Observing with the James Webb Space Telescope” a public lecture by Dr. John Mather, Nobel Laureate. 
 November 12 at 8 pm Stocker AstroScience Star Party. 
 November 13 in the MARC Pavilion—FIU’s annual Department of Energy (DOE) Induction Ceremony. 
 November 14 from 1:30 to 2:30 pm in AHC4 #101, “Single Molecule Spectroscopy of Amino Acids and Peptides by 
Recognition Tunneling” by Stuart Lindsay, Professor and Director, Center for Single Cell Molecule Biophysics 
http://sish.fiu.edu/initiatives/biomolecular-and-biomedical/archived-lectures/  
 November 15 at 12 noon in AHC1 #110 “Neurobiological Organization of Language:  Research Using High-Field 
Magnetic Resonance Imaging” by Anthony Dick—part of CCF’s Brown Bag Series. 
 November 19 and 20 at the RDB College of Law Large Courtroom, the second annual industry meeting of the 
National Science Foundation (NSF) Nanosystems Engineering Research Center (ERC) for Advanced Self-Powered 
Systems of Integrated Sensors and Technologies (ASSIST). Please register here. 
 November 20 at 9:45 am in the MARC Pavilion “Connecting Genomic Alterations to Cancer Biology with 
Proteomics” presented by Dr. Henry Rodríguez, Director of the Office of Cancer Clinical Proteomics Research at the 
National Cancer Institute, National Institutes of Health. 
 November 22 at 11 am at the College of Business Complex Room 155 (and via polycom at BBC Marine Sciences 
Building Room 105), “Accelerating and Enhancing the Drug Discovery Process” by Dr. Richard Houghten from 
Torrey Pines Institute for Molecular Studies. 
 
December 2013 
 December 3 (by invitation only) Second Annual Induction Ceremony of the FIU Chapter of the National Academy of 
Inventors. 
 December 3 3:30 to 5pm in AHC-4 #402, “Preparing for the 3rd Year Review” by Meredith Newman, Sr. Associate 
Dean (CAS) 
 December 6 at 12 noon in AHC1 #110 “The Changing Landscape of Cannabis Use and Its Impact on Neurocognitive 
Functioning” by Raúl González—part of CCF’s Brown Bag Series. 
 December 10 at 3:30 pm in the MARC Pavilion “Developing Testable Hypotheses” by  O. Dale Williams, FIU 
Professor and Chair of the Biostatistics Department. 
 
January 2014 
 January 14 from 12 to 1:30 pm at the Faculty Club, “Faculty Mentor Lunch for CAS-CEC-RSCPHSW for 
mentor/mentee pairs.” 
 January 23 & 24 from 8 am to 5 pm at the MARC Pavilion, “2014 Workshop on Origami Design for Integration of 
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Self-assembling Systems for Engineering Innovation.” 
 January 29 & 30 from 8:30 am to 5 pm at the MARC Pavilion, “Alcohol Research Center Annual Conference.” 
 
The previously announced Team Science workshop has been moved to Spring 2014. 
 
Awards Received—September 2013 
Florida International University researchers were awarded $12,903,136 in September 2013. Below is a summary: 
 
PI: Omar I Abdul Aziz 
INTERNATIONAL HURRICANE CENTER 
Award Action Type: Initial 
AWARDING SPONSOR: Florida Office of Insurance Regulation 
TITLE: Sub-Project: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm 
Surge and Flooding 2013-2014 AWARD: $ 133,098 
 
PI: Malek Adjouadi 
ELEC AND COMPUTER ENG 
Award Action Type: Continuation 
AWARDING SPONSOR: University of Texas  El Paso 
TITLE: BPC-AE: Computing Alliance of Hispanic-Serving Institutions (CAHSI) Renewal  
 AWARD: $ 36,892 
PI: Malek Adjouadi 
ELEC AND COMPUTER ENG 
Award Action Type: Continuation 
AWARDING SPONSOR: University of Texas  El Paso 
TITLE: Participant payments: BPC-AE: Computing Alliance of Hispanic Serving Institutions (CAHSI) Renewal  
 AWARD: $ 19,000 
PI: Arvind Agarwal 
MECHANICAL AND MAT ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: Clarkson Aerospace Corp 
TITLE: AFRL Collaboration Program - Materials and Manufacturing Research AWARD: $ 73,000 
 
PI: Heidi Alvarez 
CIARA 
Award Action Type: Continuation 
AWARDING SPONSOR: University of Chicago 
TITLE: Open Science Data Cloud(OSDC)PIRE:Training and Workshops AWARD: $ 115,411 
 
PI: Heidi Alvarez 
CIARA 
Award Action Type: Continuation 
AWARDING SPONSOR: University of Chicago 
TITLE: Open Science Data Cloud(OSDC)PIRE:Training and Workshops AWARD: $ 45,000 
 
PI: Ralf Arndt 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: University of Vermont 
TITLE: Condition Assessment of the First Fort Bowie and Condition Assessment of the Second Fort Bowie, Fort Bowie 
National Historic Site AWARD: $ 20,510 
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PI: Shekhar Bhansali 
ELEC AND COMPUTER ENG 
Award Action Type: Pre-Award 
AWARDING SPONSOR: North Carolina State University 
TITLE: Advanced Self-Powered Systems of Integrated Sensor Technologies (ASSIST) AWARD: $ 49,606 
 
PI: Shekhar Bhansali 
ELEC AND COMPUTER ENG 
Award Action Type: Pre-Award 
AWARDING SPONSOR: North Carolina State University 
TITLE: Participant Payments ASSIST AWARD: $ 7,200 
 
PI: Shekhar Bhansali 
ELEC AND COMPUTER ENG 
Award Action Type: Pre-Award 
AWARDING SPONSOR: North Carolina State University 
TITLE: Participant Pmts Y2 ASSIST AWARD: $ 7,200 
 
PI: Shekhar Bhansali 
ELEC AND COMPUTER ENG 
Award Action Type: Initial 
AWARDING SPONSOR: Naval Research Laboratory 
TITLE: Nanostructure Interaction Assessment of MCS Cells Using EIS Technique in a Microfluidic System  
 AWARD: $ 100,000 
PI: Eric Bishop-Von Wettberg 
BIOLOGY 
Award Action Type: Increase 
AWARDING SPONSOR: Fairchild Tropical Botanic Garden 
TITLE: Fairchild Tropical Botanic Garden supports research and education in tropical botany.  As a tangible expression of 
this support, they provide graduate student support for individuals working for higher degrees in areas of tropical plant 
science. AWARD: $ 213 
 
PI: Eric Bishop-Von Wettberg 
BIOLOGY 
Award Action Type: Initial 
AWARDING SPONSOR: University of California Davis 
TITLE: Deducing the genomic footprint and functional impact of chickpea domestication on nitrogen fixation  
 AWARD: $ 31,465 
PI: Eric Thomas Brewe 
COE TEACHING AND LEARNING 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: INSPIRE Type 1: Investigating Retention and Persistence with Network Analysis 
 AWARD: $ 338,833 
PI: David Richard Brown 
COM HUMANITIES HLTH AND SOC 
Award Action Type: Initial 
AWARDING SPONSOR: American Academy of Developmental Medicine 
TITLE: FRIEND Project AWARD: $ 10,000 
 
PI: Yong Cai 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
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TITLE: Sub Project: Florida International University's Research Support to the Department of Energy's Office of 
Environmental Management AWARD: $ 22,827 
 
PI: Shu-Ching Chen 
INTERNATIONAL HURRICANE CENTER 
Award Action Type: Initial 
AWARDING SPONSOR: Florida Office of Insurance Regulation 
TITLE: Sub-Project: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm 
Surge and Flooding 2013-2014 AWARD: $ 153,678 
 
PI: Jonathan Comer 
CENTER FOR CHILDREN AND FAM 
Award Action Type: Initial 
AWARDING SPONSOR: National Institute of Mental Health 
TITLE: Evaluating the Feasibility of Internet-Delivered Parent-Child Interaction Therapy AWARD: $ 28,192 
 
PI: Carol E Damian 
FROST ART MUSEUM 
Award Action Type: Initial 
AWARDING SPONSOR: Miami-Dade County Cultural Affairs 
TITLE: FY 2013-2014 MCI Frost Art Museum AWARD: $ 24,575 
 
PI: Jessy Devieux 
HEALTH PROMO AND DISEASE PREV 
Award Action Type: Initial 
AWARDING SPONSOR: University of California Los Angeles 
TITLE: Seed grant AWARD: $ 21,040 
 
PI: Maureen Donnelly 
BIOLOGY 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Graduate Research Fellowship Program AWARD: $ 2,000 
 
PI: Maria C Donoso 
EARTH AND ENVIRONMENT 
Award Action Type: Increase 
AWARDING SPONSOR: US Agency for International Development 
TITLE: West Africa Water Supply-Ghana AWARD: $ 1,903,254 
 
PI: Maria C Donoso 
EARTH AND ENVIRONMENT 
Award Action Type: Increase 
AWARDING SPONSOR: US Agency for International Development 
TITLE: West Africa Water Supply-Niger AWARD: $ 484,482 
 
PI: Maria-Rosa Drake 
NETWORK SERVICES 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: FlowWaves: CC-NIE Networking Infrastructure: FlowWave: Enabling 
High Bandwidth Science Data Flows AWARD: $ 275,908 
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PI: James W Fourqurean 
SOUTHEAST ENV RESEARCH CTR 
Award Action Type: Continuation 
AWARDING SPONSOR: National Park Service 
TITLE: The South Florida Caribbean Inventory and Monitoring Network Undergraduate Internship and Training Program  
 AWARD: $ 94,938 
PI: James W Fourqurean 
BIOLOGY 
Award Action Type: Increase 
AWARDING SPONSOR: University of Miami 
TITLE: Aquarius Reef Base AWARD: $ 500,086 
 
PI: Rebecca Friedman 
SIPA 
Award Action Type: Increase 
AWARDING SPONSOR: European Commission 
TITLE: Miami-Florida European Center of Excellence AWARD: $ 3,000 
 
PI: Cheng-Tin Gan 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: Florida Department of Transportation 
TITLE: Feasibility of a Web-Based System for Police Report Review and Information Recording  
 AWARD: $ 90,000 
PI: Stavros Georgakopoulos 
ELEC AND COMPUTER ENG 
Award Action Type: Initial 
AWARDING SPONSOR: Georgia Institute of Technology 
TITLE: EFRI-ODISSEI: Novel Perpetual Reconfigurable & Multi-Band "Origami Folding/Unfolding" Electromagnetic 
Systems for Cognitive Intelligence Applications AWARD: $ 683,766 
 
PI: Mohammed A Hadi 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: University of Florida 
TITLE: STRIDE Internship-Amauris Ramirez AWARD: $ 7,427 
 
PI: Shahid Hamid 
INTERNATIONAL HURRICANE CENTER 
Award Action Type: Initial 
AWARDING SPONSOR: Florida Office of Insurance Regulation 
TITLE: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm Surge and 
Flooding 2013-2014 AWARD: $ 833,253 
 
PI: Shahid Hamid 
INTERNATIONAL HURRICANE CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Florida Office of Insurance Regulation 
TITLE: Sub-Contracts: Florida Public Hurricane Loss Model Project Model Enhancements to Estimate Losses from Storm 
Surge and Flooding 2013-2014 AWARD: $ 423,271 
 
PI: Jin He 
PHYSICS 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
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TITLE: Carbon nanotube based nanofluidic device for biological sensing AWARD: $ 308,623 
 
PI: Michael Heithaus 
BIOLOGY 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Graduate Research Fellowship Program AWARD: $ 2,000 
 
PI: Michelle M Hospital 
PSYCHOLOGY 
Award Action Type: Initial 
AWARDING SPONSOR: Ware Foundation 
TITLE: Enhancing Resilience among At-Risk Minority Youth through Music Education: An Evaluation of ESMIA (aka, 
Project TREBLE). Resilience among at Risk Minority Youth through Music Education: An Evaluation of ESMIA 
 AWARD: $ 30,000 
PI: Kenneth Arthur Jessell 
DIVISION OF FINANCE AND ADMIN 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: UniversityCity Prosperity Project AWARD: $ 100,000 
 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU AWARD: $ 5,000 
 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: Mohammaafali 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU  
 AWARD: $ 3,000 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: Fakharian  Qom '13 Felllowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU 
 AWARD: $ 3,000 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: Crean 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU  
 AWARD: $ 10,000 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
TITLE: Johnson 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU  
 AWARD: $ 7,500 
PI: Sylvan C Jolibois 
CIVIL AND ENVIRON ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of Transportation 
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TITLE: Edmonson 2013 Fellowship: 2013 Dwight D. Eisenhower Transportation Fellowship Program at FIU  
 AWARD: $ 5,000 
PI: Ranu Jung 
BIOMEDICAL ENGINEERING 
Award Action Type: Increase 
AWARDING SPONSOR: FIU Foundation 
TITLE: Cardiovascular Engineering Center Fund AWARD: $ 10,000 
 
PI: Ranu Jung 
BIOMEDICAL ENGINEERING 
Award Action Type: Increase 
AWARDING SPONSOR: FIU Foundation 
TITLE: Biomedical Engineering Exercise Scholarship Fund AWARD: $ 12,500 
 
PI: Leonel Lagos 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
TITLE: FIU's Research Support to Dept. of Energy's Office of Environmental Management AWARD: $ 271,215 
 
PI: Leonel Lagos 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
TITLE: Sub Project 1: FIU's Research Support to Dept. of Energy's Office of Environmental Management 
 AWARD: $ 256,343 
PI: Leonel Lagos 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
TITLE: FIU's Research Support to Dept. of Energy's Office of Environmental Management AWARD: $ 114,496 
 
PI: Leonel Lagos 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
TITLE: Sub Project 3- Remediation: FIU's Research Support to Dept. of Energy's Office of Environmental Management 
 AWARD: $ 144,647 
PI: Leonel Lagos 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Increase 
AWARDING SPONSOR: Office of Environmental Management 
TITLE: Subproject -Waste and D&D Eng: FIU's Research Support to Dept. of Energy's Office of Environmental 
Management AWARD: $ 278,618 
 
PI: Chenzhong Li 
BIOMEDICAL ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: SubProject: Carbon nanotube based nanofluidic device for biological sensing AWARD: $ 76,377 
 
PI: Robert Lickliter 
DOR - DIVISION OF RESEARCH 
Award Action Type: Increase 
AWARDING SPONSOR: General Medical Sciences 
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TITLE: FIU MBRS RISE - Administrative: MBRS Research Initiative for Scientific Enhancement  
 AWARD: $ 111,214 
PI: Robert Lickliter 
DOR - DIVISION OF RESEARCH 
Award Action Type: Increase 
AWARDING SPONSOR: General Medical Sciences 
TITLE: FIU MBRS RISE - Trainee: MBRS Research Initiative for Scientific Enhancement  
 AWARD: $ 802,767 
PI: Christine Lisetti 
COMPUTER INFO SCIENCES 
Award Action Type: Initial 
AWARDING SPONSOR: Inst for Disabilities Rsrch & Training 
TITLE: American Sign Language Literacy Support System AWARD: $ 70,000 
 
PI: Hong Liu 
EARTH AND ENVIRONMENT 
Award Action Type: Increase 
AWARDING SPONSOR: Fairchild Tropical Botanic Garden 
TITLE: GA for the Fairchild Challenge educational program AWARD: $ 293 
 
PI: Hong Liu 
EARTH AND ENVIRONMENT 
Award Action Type: Increase 
AWARDING SPONSOR: Fairchild Tropical Botanic Garden 
TITLE: Conservation ecology of selected plants in Halmahera, Indonesia Graduate Assistantship for Melissa Abdo  
 AWARD: $ 188 
PI: Lindsay Malloy 
PSYCHOLOGY 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Graduate Research Fellowship Program AWARD: $ 2,000 
 
PI: Kalai Mathee-narasimhan 
COM HUMAN AND MOL GENETICS 
Award Action Type: Initial 
AWARDING SPONSOR: FIU Division of Research 
TITLE: BRIDGE Funding 13-14 AWARD: $ 8,742 
 
PI: Anthony McGoron 
BIOMEDICAL ENGINEERING 
Award Action Type: Initial 
AWARDING SPONSOR: National Institutes of Health 
TITLE: Novel Polymeric nanoparticles for drug delivery applications AWARD: $ 155,102 
 
PI: Masoud Milani 
COMPUTER INFO SCIENCES 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: RET in Engineering and Computer Site: Nanotechnology Research Experiences for Teachers at FIU  
 AWARD: $ 95,903 
PI: Masoud Milani 
COMPUTER INFO SCIENCES 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
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TITLE: Participant Payments: RET in Engineering and Computer Site: Nanotechnology Research Experiences for 
Teachers at FIU AWARD: $ 384,000 
 
PI: Osama A Mohammed 
ELEC AND COMPUTER ENG 
Award Action Type: Continuation 
AWARDING SPONSOR: Office of Naval Research 
TITLE: Real Time Modeling & Simulation Techniques using Intelligent Systems with a Reduced Scale Hardware 
Demonstration of Smart Controls for Notional Ship Architecture AWARD: $ 110,000 
 
PI: Giri Narasimhan 
COMPUTER INFO SCIENCES 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Graduate Research Fellowship Program AWARD: $ 2,000 
 
PI: Olga Nazario 
ARC APPLIED RESEARCH CENTER 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of State 
TITLE: Energy and Climate Partnership of the Americas (ECPA) grant AWARD: $ 157,416 
 
PI: Adly Norelus 
STUDENT AFFAIRS VICE PRES OFF 
Award Action Type: Initial 
AWARDING SPONSOR: Florida Department of Agriculture and Co 
TITLE: Summer Food Service Program AWARD: $ 11,187 
 
PI: Laura A Ogden 
SOUTHEAST ENV RESEARCH CTR 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Graduate Research Fellowship Program AWARD: $ 2,000 
 
PI: Mark Benjamin Padilla 
CENTER FOR CHILDREN AND FAM 
Award Action Type: Initial 
AWARDING SPONSOR: National Institute on Drug Abuse 
TITLE: Migration, Tourism and the HIV-drug use Syndemic in the Dominican Republic 
 AWARD: $ 451,646 
PI: Rene Price 
SOUTHEAST ENV RESEARCH CTR 
Award Action Type: Increase 
AWARDING SPONSOR: South Florida Water Management District 
TITLE: Hydrological Conditions of Mangrove Lakes Region of Everglades National Park  
 AWARD: $ 36,891 
PI: Raphael G Raptis 
CHEMISTRY 
Award Action Type: Initial 
AWARDING SPONSOR: American Chemical Society 
TITLE: Synthesis and Characterization of Dyads Capable of Achieving  
Photoexcited Two-Electron Charge-Separated States AWARD: $ 92,553 
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PI: Jennifer H Richards 
BIOLOGY 
Award Action Type: Increase 
AWARDING SPONSOR: Fairchild Tropical Botanic Garden 
TITLE: Fairchild Tropical Botanic Garden supports research and education in tropical botany.  As a tangible expression of 
this support, they provide graduate student support for individuals working for higher degrees in areas of tropical plant 
science. AWARD: $ 213 
 
PI: Naphtali Rishe 
COMPUTER INFO SCIENCES 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: I/UCRC Phase II: Center for Advanced Knowledge Enablement AWARD: $ 81,750 
 
PI: Camilo Rosales 
ARCHITECTURE 
Award Action Type: Initial 
AWARDING SPONSOR: U.S. Department of State 
TITLE: Energy and Climate Partnership of the Americas (ECPA) grant AWARD: $ 616,643 
 
PI: Michael S Ross 
SOUTHEAST ENV RESEARCH CTR 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Army 
TITLE: Landscaping  Pattern: Marl Praire/Slough Gradients AWARD: $ 96,281 
 
PI: Michael S Ross 
SOUTHEAST ENV RESEARCH CTR 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Army 
TITLE: Monitoring of Tree Island Condition in South Everglades AWARD: $ 92,667 
 
PI: Ernest Simms 
STUDENT AFFAIRS VICE PRES OFF 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Department of Education 
TITLE: Educational Talent Search AWARD: $ 217,971 
 
PI: Ernest Simms 
STUDENT AFFAIRS VICE PRES OFF 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Department of Education 
TITLE: McNair 2012-2017 AWARD: $ 218,915 
 
PI: Ernest Simms 
STUDENT AFFAIRS VICE PRES OFF 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Department of Education 
TITLE: Upward Bound Math-Science 12-17 AWARD: $ 217,472 
 
PI: Ernest Simms 
STUDENT AFFAIRS VICE PRES OFF 
Award Action Type: Continuation 
AWARDING SPONSOR: U.S. Department of Education 
TITLE: Subproject: Upward Bound Math-Science 12-17 AWARD: $ 19,418 
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PI: Mary Jo Trepka 
EPIDEMIOLOGY 
Award Action Type: Increase 
AWARDING SPONSOR: Minority Health and Health Disparities 
TITLE: Retrospective cohort study of racial disparities in HIV survival, Florida AWARD: $ 100,000 
 
PI: Yi Xiao 
CHEMISTRY 
Award Action Type: Initial 
AWARDING SPONSOR: National Institute of Justice 
TITLE: Aptamer-Based, Exonuclease-Amplified, Paper Device for Point of Collection Screening of Cocaine and 
Methamphetamine in Oral Fluid AWARD: $ 352,223 
 
PI: Changwon Yoo 
BIOSTATISTICS 
Award Action Type: Continuation 
AWARDING SPONSOR: National Institutes of Health 
TITLE: Identifying Key Genes that cause Aggressive Brain Cancer AWARD: $ 104,944 
 
PI: Yimin Zhu 
CONSTRUCTION MANAGEMENT 
Award Action Type: Initial 
AWARDING SPONSOR: National Science Foundation 
TITLE: Collaborative Research: Cyber-Constructor: Enhancing spatial and temporal cognitive ability in construction 
education through augmented reality AWARD: $ 50,793 
 
PI: Yimin Zhu 
CONSTRUCTION MANAGEMENT 
Award Action Type: Initial 
AWARDING SPONSOR: University of North Texas 
TITLE: RCN-SEES: Predictive Modeling Network for Sustainable Human-Building Ecosystems (SHBE)  
 AWARD: $ 31,500 
PI: Yimin Zhu 
CONSTRUCTION MANAGEMENT 
Award Action Type: Initial 
AWARDING SPONSOR: University of North Texas 
TITLE: Participant Payments: RCN-SEES: Predictive Modeling Network for Sustainable Human-Building Ecosystems 
(SHBE) AWARD: $ 31,000 
 
Limited Submission Funding Opportunities 
Below are limited submission funding opportunities with internal deadlines for the month of November 2013.  
 
Agency: Miami Dade County Department of Cultural Affairs 
Program: FY 2013-2014 TOURIST DEVELOPMENT COUNCIL GRANTS PROGRAM 
Institutional Submission 
Limits: 
Two applications per fiscal year.  *This is contingent upon the number of applications we 
receive based on Miami-Dade County's fiscal year (October 1 - September 30) 
Internal Proposal Deadline: 11/15/2013  internal proposal application 
Agency Deadline: 1/16/2014 
Status: Open 
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Link: 
http://miamidadearts.culturegrants.org/navigation/links/page/tourist-development-council-
tdc 
Agency: National Institutes of Health 
Program: 
Centers of Excellence for Research on CAM (P01) - AIDS Application  
(PAR-12-151) 
Institutional Submission 
Limits: 
Only one application per institution is allowed. 
Internal Proposal Deadline: 11/25/2013  internal proposal application 
Agency Deadline: AIDS Application: 01/07/2014 
Status: Open 
Link: http://grants.nih.gov/grants/guide/pa-files/PAR-12-151.html  
 
Please visit our website at: http://research.fiu.edu/funding/pages/limited-submissions.html to review our monthly limited 
submissions or for further instructions on how to prepare and/or submit your limited submission application. 
Funding Opportunities 
Department of  Defense 
Sea-Based Aviation National Naval Responsibility (SBA NNR) Structures and Materials Focus Area  
Funding Opportunity Number: 13-SN-0025  
Application Deadline: February 28, 2014  
Description: This announcement describes the Sea-based Aviation National Naval Responsibility (SBA NNR) Structures 
and Materials Focus Area research opportunity to be launched under the ONRBAA14-001, Long Range Broad Agency 
Announcement for Navy and Marine Corps Science and Technology. The purpose of this announcement is to focus 
attention of the scientific community on (1) the areas to be studied, and (2) the planned timetable for the initial round of 
white paper submissions. http://www.grants.gov/search-
grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
 
U.S. Army Medical Research and Materiel Command Broad Agency Announcement  
Funding Opportunity Number:   W81XWH-BAA-14-1  
Application Deadline: September 30, 2014  
Description: The U.S. Army Medical Research and Materiel Command's (USAMRMC) mission is to provide solutions to 
medical problems of importance to the American Service member at home and abroad, as well as to the general public at 
large. The scope of this effort and the priorities attached to specific projects are influenced by changes in military and 
civilian medical science and technology, operational requirements, military threat assessments, and national defense 
strategies. The extramural research and development program plays a vital role in the fulfillment of the objectives 
established by the USAMRMC. General information on USAMRMC can be obtained at https://mrmc.detrick.army.mil/. 
This BAA is intended to solicit extramural research and development ideas, and is issued under the provisions of the 
Competition in Contracting Act of 1984 (Public Law 98-369), as implemented in Federal Acquisition Regulation 
6.102(d)(2) and 35.016. This BAA provides a general description of USAMRMC’s research and development programs, 
including: research areas of interest; general information; evaluation and selection criteria; and proposal/application 
preparation instructions. Research and development funded through this BAA is intended and expected to benefit and 
inform both military and civilian medical practice and knowledge. In accordance with FAR 6.102, projects funded under 
this BAA must be for basic and applied research and that part of development not related to the development of a specific 
system or hardware procurement. Projects must be for scientific study and experimentation directed toward advancing the 
state-of-the-art or increasing knowledge or understanding rather than focusing on a specific system or hardware solution. 
This is a continuously open announcement; pre-proposal/pre-applications and full proposal/full applications may be 
submitted at any time throughout the 12-month period. However, no proposal/application submitted under this BAA will 
be considered for funding after 24 months from the date of submission. Before submitting full proposal/applications, 
organizations are strongly encouraged to explore USAMRMC interest by submitting preliminary research 
proposal/applications (pre-proposal/pre-applications). Pre-proposal/pre-applications may be submitted at any time prior to 
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the BAA closing date. This fiscal year’s BAA contains several changes from previous USAMRMC BAAs: research areas 
of interest have been updated; instructions are provided for marking proprietary information if included in full 
proposals/applications; information and instructions regarding Conflicts of Interest have been added; in addition to current 
and pending support information, PIs and key personnel are required to provide prior (within the last 5 years) support 
information; areas addressing Representations and Certifications have changed; attachment entitled “Organizational Data” 
is added; attachment previously entitled “Certificate of Environmental Compliance” is changed to “Environmental 
Compliance Assurance”; attachment entitled “Facility Safety Plan Instructions” has been updated.  
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
 
Hypoxia Monitoring, Alert, and Mitigation System Funding Opportunity Number:  14-SN-0002  
Application Deadline: November 22, 2013  
Description: This announcement describes a research thrust entitled “Hypoxia Monitoring, Alert and Mitigation System” 
(HAMS) to be launched under the ONR BAA 14-001, Long Range Broad Agency Announcement (BAA) for Navy and 
Marine Corps Science and Technology which can be found at: http://www.onr.navy.mil/Contracts-Grants/Funding-
Opportunities/Broad-Agency-Announcements.aspx. The research opportunity described in this announcement specifically 
falls under numbered paragraph 2 (item c) of the sub-section entitled Warfighter Performance (Warfighter Protection and 
Applications). The submission of proposals, their evaluation and potential execution of funds will be carried out as 
described in that BAA. The purpose of this announcement is to focus attention of the scientific community on the area to 
be studied and the planned timetable for the submission of proposals. The FULL ANNOUNCEMENT is available on the 
Grants.gov website by scrolling to the top of the synopsis page and clicking on the "FULL ANNOUNCEMENT" box 
surrounded by the dotted line at the top of the page.  http://www.grants.gov/search-
grants.html?agencies%3DDOD%7CDepartment%20of%20Defense 
 
DoD Breast Cancer Postdoctoral Fellowship Award  
Funding Opportunity Number:   W81XWH-13-BCRP-POSTDOC2  
Application Deadline: January 9, 2014  
Description: The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in 
pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the 
necessary experience for an independent career at the forefront of breast cancer research. Those individuals should be 
exceptionally talented scientists who have demonstrated that they are the “best and brightest” of their peers. Applicants 
for this award must exhibit a strong desire to pursue a career in breast cancer research. Under this award mechanism, the 
postdoctoral fellow is considered the Principal Investigator (PI) and, as such, should write the project narrative, training 
plan, and other application components with appropriate guidance from the mentor. While the PI is not required to have 
previous experience in breast cancer research, the proposed project and training must focus on breast cancer. Applications 
must emphasize the PI’s high potential for success in becoming an independent breast cancer researcher based on his/her 
qualifications, achievements (including first-author publications), and letters of recommendation. The mentor (or co-
mentor, if applicable) must possess the appropriate expertise and experience in breast cancer, to include publications and 
active peer reviewed breast cancer funding, and clearly demonstrate a commitment to guiding the PI’s research and 
training. If the mentor is not an experienced breast cancer researcher, then formal co-mentorship by an established breast 
cancer researcher is required. The application must include information about the mentor’s experience in conducting 
innovative research and how he/she intends to support the PI’s endeavors in breast cancer. Mentorship by an investigator 
without an established record of mentoring pre- and postdoctoral trainees may be offset by the overall strength of the 
training plan. Applications must provide details on the suitability of the PI’s overall training plan and research project for 
attaining the goals of this award mechanism. Applications must elaborate on the qualities of the training environment in 
which the candidate will work, provide details on the individualized, breast cancer-focused training plan, and describe 
how this training will facilitate the PI’s career development as an independent, innovative breast cancer researcher. A 
multidisciplinary research approach to breast cancer is highly encouraged but not required; however, if there are 
multidisciplinary aspects to the training, they should be clearly outlined in the application. The application must articulate 
the potential impact that the proposed work will have on breast cancer. The research should be based on a sound scientific 
rationale and/or a thorough review of the literature. Preliminary data are not required. http://www.grants.gov/search-
grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
 
Systems-Based Neurotechnology for Emerging Therapies (SUBNETS)  
Funding Opportunity Number:  DARPA-BAA-14-09  
Application Deadline: December 17, 2013  
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Description: DARPA seeks to develop a new understanding of complex, systems-based disorders of the brain. A major 
goal of this effort is to deliver a platform technology for precise therapy in humans living with neuropsychiatric and 
neurologic disease, including veterans and active duty soldiers suffering from mental health issues. Methods developed 
through this program will use neural recording and stimulation to close the loop on therapeutic treatment in individuals 
who receive minimal benefits from currently available treatments. This program could lead to improved knowledge of 
multiple neural subnetworks of the brain that are involved in disease and illness. This program combines novel device 
development, complex modeling of behaving human neural systems, clinical neurology, and animal research in order to 
advance the understanding and translation of safe, effective neuro-technological therapies.  
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
 
DoD Clinical and Rehabilitative Medicine Neurosensory Research Award  
Funding Opportunity Number:   W81XWH-13-DMRDP-CRMRP-NSRA  
Application Deadline: February 11, 2014  
Description: The FY13 DMRDP CRMRP Neurosensory Research Award (NSRA) is intended to support both applied 
(preclinical) research and clinical trials within specific Focus Areas of pain management, hearing loss/dysfunction, 
balance disorders, and/or tinnitus. Applications focused on traumatic brain injury (TBI) are highly encouraged.  
http://www.grants.gov/search-grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
 
DoD Clinical and Rehabilitative Medicine Neuro-musculoskeletal Injuries Research Award  
Funding Opportunity Number: W81XWH-14-DMRDP-CRMRP-NMSIRA  
Application Deadline: February 11, 2014  
Description: The FY14 DMRDP CRMRP Neuro-musculoskeletal Injuries Research Award (NMSIRA) supports 
preclinical research and clinical trials on the functional utility of assistive devices related to the human-device interface, 
secondary health effects following severe extremity injury, and optimizing rehabilitation and device prescription for 
patients with severe extremity trauma. To meet the intent of the award mechanism, applications must specifically address 
one or more of the FY14 DMRDP CRMRP NMSIRA Focus Areas listed below. Applications proposing research outside 
of the Focus Areas listed below should not be submitted in response to this Program Announcement/Funding Opportunity. 
 Improving the functional utility of assistive devices related to the human-device interface (prostheses, orthoses, and 
other assistive devices) 
 Improvements in prosthetic socket comfort, residual limb health, and function 
 Providing proprioceptive and other sensory inputs to the user 
 Improving user intent control of assistive devices 
 Improving the ability to predict, identify and reduce secondary health effects that develop after severe primary neuro-
musculoskeletal injury 
 Determining factors that predict development and successful treatment of osteoarthritis, low back pain, or other 
musculoskeletal conditions 
 Intervention strategies to diminish falls and decrease fracture risk 
 Strategies to improve treatment and rehabilitation of heterotopic ossification 
 Optimizing treatment strategies and sequence of progression throughout the rehabilitation process following severe 
extremity trauma 
 Determining the optimal combination, dose, and timing of rehabilitative techniques to minimize impairments and 
maximize function and performance 
 Objectively guiding prosthetic and/or orthotic prescription to minimize impairments and maximize function and 
performance 
If the proposed study involves the use of a drug or biologic that has not been approved by the Food and Drug 
Administration (FDA) for its investigational use, evidence that an Investigational New Drug (IND) exemption application 
has been submitted or will be submitted within 60 days of award is required. If the proposed study involves an 
Investigational Device that has not been approved or cleared by FDA for its investigational clinical use, the study may be 
required to comply with the FDA Investigational Device Exemption (IDE) regulations and evidence that an IDE has been 
submitted or will be submitted within 60 days of the award date or that the device is exempt from an IDE is required. The 
Government reserves the right to withdraw funding if the IND or IDE application has not been submitted to the FDA 
within 60 days of the DoD award date or if the documented status of the IND or IDE has not been obtained within 6 
months of the award date.  http://www.grants.gov/search-
grants.html?agencies%3DDOD%7CDepartment%20of%20Defense  
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Environmental Protection Agency 
Urban Waters Small Grants  
Funding Opportunity Number: EPA-OW-IO-13-01  
Application Deadline: Nov 25, 2013  
Description: Under this announcement, the U.S. Environmental Protection Agency (EPA) is soliciting proposals from 
eligible applicants for projects that will advance EPA’s water quality and environmental justice goals. Note that, for this 
grant cycle, projects proposed for funding must take place entirely within and focus on one of 18 specific Eligible 
Geographic Areas, as listed in Section I.A and illustrated on the Urban Waters Small Grants program mapping website 
http://www2.epa.gov/urbanwaters/urban-waters-small-grants-mapping 
http://www2.epa.gov/urbanwaters/urban-waters-small-grants   
http://www2.epa.gov/sites/production/files/2013-09/documents/uwsg-rfp-09262013_0.pdf 
 
FY 2014 National Environmental Information Exchange Network Grant Program  
Funding Opportunity Number:  EPA-OEI-14-01  
Application Deadline: Nov 8, 2013   
Description: The Exchange Network Grant Program provides funding to states, tribes, inter-tribal consortia and territories 
to develop and implement the information technology and information management capabilities they need to actively 
participate in the Exchange Network. This grant program supports the exchange of environmental data and collaborative 
work within the Exchange Network. Grantees will share work products with all EN partners through EPA’s Reusable 
Component Services (RCS) database. http://epa.gov/exchangenetwork/grants/  
 
Gulf of Mexico Regional Partnerships – 2013  
Funding Opportunity Number:  EPA-GM-2013-1  
Application Deadline: Nov 12, 2013   
Description: The U.S. Environmental Protection Agency (EPA) – Gulf of Mexico Program (GMP) is soliciting initial 
proposals under this announcement from eligible entities that address water quality monitoring and/or improvement, 
coastal habitat and ecosystems enhancement and/or protection, community resilience, and environmental education and 
outreach in the Gulf of Mexico region and its watersheds. The initial proposals will be short submissions describing a 
project’s scope and environmental results, and will be evaluated to determine whether the applicant will be requested to 
submit a full proposal. A broad range of entities, as described in Section III, are eligible to submit proposals under this 
announcement for projects in the Gulf of Mexico region and its watersheds in the five states abutting the Gulf of Mexico 
(Texas, Louisiana, Mississippi, Alabama, Florida), including their out-of-geographic-region contributory watersheds, that 
address water quality monitoring and/or improvement, coastal habitat and ecosystems enhancement and/or protection, 
community resilience and environmental education and outreach. http://epa.gov/gmpo/  
 
Organotypic Culture Models for Predictive Toxicology Center  
Funding Opportunity Number:  EPA-G2013-STAR-L1  
Application Deadline: Jan 23, 2014  
Description: The U.S. Environmental Protection Agency (EPA), as part of its Science to Achieve Results (STAR) 
program, is seeking applications for research centers to investigate toxic effects of chemical substances in three-
dimensional (3D) in vitro models, hereafter referred to as ‘organotypic culture models’ (OCMs). OCMs are tissue culture 
models that mimic in vivo tissue architecture through interactions of heterotypic cell types (e.g., epithelium-stroma) and 
extracellular matrices (ECM). They can be established from isolated cells or from tissue fragments harvested in vivo, and 
will bridge the gap between conventional monolayer cell cultures and whole-animal systems. EPA is interested in the 
potential application of OCMs that mimic complex cell arrangements and physiologies, scalable from mid to higher 
throughput screening (HTS), and high-content screening (HCS) approaches. This solicitation seeks the formation of 
research centers that will guide the development and evaluation of OCMs that will accelerate translational research in 
predictive toxicology. http://www.epa.gov/ncer/rfa/2013/2013_star_ocm.html  
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Florida Department of  Health & Sanford-Burnham Medical Research Institute 
Florida Translational Research Program  
Funding Opportunity Number: N/A     
Pre-Application Deadline: N/A     
Application Deadline: Thursday, November 7, 2013, 5:00 p.m. EST  
Description: The purpose of the Florida Translational Research Program (FTRP) is to produce a pipeline of potential new 
medicines based upon laboratory research discoveries. The Program provides Florida-based scientists with access to 
experienced professionals and state-of-the-art technological resources for drug discovery to facilitate an interdisciplinary, 
collaborative approach to the establishment of a pipeline of potential new treatments for today’s most challenging and 
unmet medical needs. The Program is funded by the state of Florida through the Florida Department of Health and is 
administered and performed by Sanford-Burnham Medical Research Institute at Lake Nona. The goals of the FTRP are to 
implement a variety of innovative biochemical and cell-based assays to interrogate biological targets or processes for 
which there are limited selective and potent small-molecule modulators available; to execute high-throughput screens; and 
to develop lead compounds suitable for use in vivo. To meet these objectives the Program seeks three types of early drug 
discovery project proposals: 
 Concept or assay development projects for use in pre-therapeutic discovery via high-throughput screening. This 
solicitation invites proposals for the development of innovative biochemical and cell-based assays for biological 
targets, pathways, or processes for which there are limited selective and potent small-molecule modulators available. 
 High-throughput screening (HTS)-ready assays. This solicitation seeks well-developed, HTS-ready assays suitable for 
high-throughput screening of the Sanford-Burnham library of compounds for the purpose of identifying small-
molecule modulators of the target, pathways, or processes of interest. 
 Validated hits for the discovery of pre-therapeutic lead compounds. This solicitation invites proposals that aim to 
further research and development of existing small-molecule chemical scaffolds for use in vivo. 
http://www.sanfordburnham.org/technology/centers/cpccg/floridatranslationalresearchprogram/Pages/Program-
Description.aspx 
 
Institute of  Museum and Library Services 
Museums of America  
Funding Opportunity Number: MFA-FY14  
CFDA Number(s): 45.301  
Deadline for Transmittal of Applications: December 2, 2013  
Description: The Museums for America (MFA) program supports projects that strengthen the ability of an individual 
museum to serve its public. MFA grants support activities that strengthen museums as active resources for lifelong 
learning, as important institutions in the establishment of livable communities, and as good stewards of the nation’s 
collections. MFA grants can fund both new and ongoing museum activities and programs. Examples include planning, 
managing and conserving collections, improving public access, training, conducting programmatic research, school and 
public programming, producing exhibitions, and integrating new or upgraded technologies into your operations. There are 
three categories within the MFA program: 
1. Learning Experiences IMLS 
2. Community Anchors IMLS 
3. Collections Stewardship 
http://www.imls.gov/applicants/detail.aspx?GrantId=11 or www.grants.gov and search by opportunity number.  
 
Sparks! Ignition Grants for Museums  
Funding Opportunity Number: SPARKS-FY14  
CFDA Number(s): 45.312  
Deadline for Transmittal of Applications: December 2, 2013  
Description: The Sparks! Ignition Grants for Museums program is a special funding opportunity within the IMLS 
National Leadership Grants for Museums program, which supports projects that address problems, challenges, or needs of 
broad relevance to museums. These small grants encourage museums to prototype and evaluate specific innovations in the 
ways they operate and the services they provide resulting in new tools, products, services, or organizational practices.  
http://www.imls.gov/applicants/detail.aspx?GrantId=23 or www.grants.gov and search by opportunity number.  
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National Leadership Grants for Museums  
Funding Opportunity Number: NLG-MUSEUMS-FY14  
CFDA Number(s): 45.312  
Deadline for Transmittal of Applications: December 2, 2013  
Description: National Leadership Grants (NLG) for Museums support projects that address current and future needs of 
the museum field and that have the potential to advance practice in the profession so that museums can improve services 
for the American public. Successful proposals will generate results such as models, new tools, research findings, services, 
practices, and/or alliances that can be widely used, adapted, scaled, or replicated to extend and leverage the benefits of 
federal investment.  Applications should align with one of the following three funding categories: 
1. Learning Experiences IMLS 
2. Community Anchors IMLS 
3. Collections Stewardship 
http://www.imls.gov/applicants/detail.aspx?GrantId=22 or www.grants.gov and search by opportunity number.  
 
Miami-Dade County Department of  Cultural Affairs 
Audience Access Grant Program  
Funding Opportunity Number: N/A  
Application Deadline: Ongoing  
Description: The Department of Cultural Affairs is committed to continuing its collaborative efforts in working with 
people with disabilities and cultural/community organizations to help address ADA compliance issues, programmatic 
accessibility, and audience development and outreach efforts. The Department strives to ensure that all of its grantees are 
likewise committed to making their facilities and programs accessible to people of all abilities. The Audience Access 
Grant Program is designed to provide funding to promote and help pay for arts program ADA/access technology, such as 
American Sign Language (ASL) interpreters, captioning, audio description, marketing materials, and other such services 
to ensure programmatic access for audiences of all abilities. This program is not intended to provide assistance in funding 
capital/facilities improvements, such as construction, renovation or major equipment purchases.  
http://miamidadearts.culturegrants.org/navigation/links/page/audience-access-aud  
 
National Aeronautics & Space Administration 
Ocean Salinity Field Campaign  
Funding Opportunity Number: NNH13ZDA001N-OSFC   
Pre-Application Deadline: November 1, 2013  
Application Deadline: December 2, 2013  
Description: The objective of this program element is to select additional members to the NASA Ocean Salinity Science 
Team for the analysis phase of a 2012-13 Ocean Salinity Field Campaign. This field campaign is known as the Salinity 
Processes in the Upper-Ocean Regional Study (SPURS). The planned work coincides with the U.S.-Argentine 
Aquarius/SAC-D and European SMOS surface salinity satellite missions, as well as the continuing, global array of ARGO 
profiling floats, all of which provide excellent new tools to monitor ocean salinity. The SPURS field campaign is 
underway (http://SPURS.jpl.nasa.gov) and this announcement anticipates the need for both analysis work and planning for 
the next SPURS campaign (in a high precipitation, low salinity location circa 2015). 
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId={1A42808C-0423-D8B5-34F9-
AAEE83031C2F}&path=open  
Space Technology Research Fellowships  
Funding Opportunity Number: NSTRF14      
Application Deadline: November 13, 2013  
Description: This call for graduate student fellowship applications, entitled NASA Space Technology Research 
Fellowships (NSTRF) – Fall 2014 (NSTRF14), solicits applications from individuals pursuing or planning to pursue 
master’s (e.g., M.S.) or doctoral (e.g., Ph.D.) degrees in relevant space technology disciplines at accredited U.S. 
universities. NASA Space Technology Fellows will perform innovative space technology research and will improve 
America’s technological competitiveness by providing the Nation with a pipeline of innovative space technologies.  
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId=%7bBD3F49F4-611F-D9EC-1B84-
16F4D7551609%7d&path=open 
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National Endowment for the Arts 
NEA Our Town Application, FY 2014  
Funding Opportunity Number: 2014NEA01OT  
Application Deadline: January 13, 2014  
Description: The Arts Endowment's support of a project may start on or after September 1, 2014. “Grant Program 
Description” Art works to improve the lives of America’s citizens in many ways. Communities across our nation are 
leveraging the arts and engaging design to make their communities more livable with enhanced quality of life, increased 
creative activity, a distinct sense of place, and vibrant local economies that together capitalize on their existing assets. The 
NEA defines these efforts as the process of Creative Place Making: "In creative place making, partners from public, 
private, nonprofit, and community sectors strategically shape the physical and social character of a neighborhood, town, 
tribe, city, or region around arts and cultural activities. Creative place making animates public and private spaces, 
rejuvenates structures and streetscapes, improves local business viability and public safety, and brings diverse people 
together to celebrate, inspire, and be inspired." Ann Markusen, Markusen Economic Research Services Anne Gadwa 
Nicodemus, Metris Arts Consulting From Creative Place making Through Our Town, subject to the availability of 
funding, the National Endowment for the Arts will provide a limited number of grants, ranging from $25,000 to $200,000, 
for creative place making projects that contribute toward the livability of communities and help transform them into 
lively, beautiful, and sustainable places with the arts at their core. http://www.grants.gov/web/grants/search-grants.html  
 
National Endowment for the Humanities 
Collaborative Research  
Funding Opportunity Number:   20140107-RZ  
Application Deadline: Jan 7, 2014  
Description: Collaborative Research Grants support interpretive humanities research undertaken by a team of two or 
more scholars, for full-time or part-time activities for periods of one to three years. Support is available for various 
combinations of scholars, consultants, and research assistants; project-related travel; field work; applications of 
information technology; and technical support and services. All grantees are expected to communicate the results of their 
work to the appropriate scholarly and public audiences. Eligible projects include ¿ research that significantly adds to 
knowledge and understanding of the humanities; ¿ conferences on topics of major importance in the humanities that will 
benefit scholarly research; ¿ archaeological projects that include the interpretation and communication of results (projects 
may encompass excavation, materials analysis, laboratory work, field reports, and preparation of interpretive 
monographs); and ¿ research that uses the knowledge and perspectives of the humanities and historical or philosophical 
methods to enhance understanding of science, technology, medicine, and the social sciences. Collaborative Research 
Grants support interpretive humanities research undertaken by a team of two or more scholars, for full-time or part-time 
activities for periods of one to three years. Support is available for various combinations of scholars, consultants, and 
research assistants; project-related travel; field work; applications of information technology; and technical support and 
services. All grantees are expected to communicate the results of their work to the appropriate scholarly and public 
audiences. http://www.grants.gov/web/grants/search-grants.html 
Scholarly Editions and Translations  
Funding Opportunity Number:   20140107-RQ  
Application Deadline: Jan 7, 2014  
Description: Scholarly Editions and Translations grants support the preparation of editions and translations of pre-
existing texts and documents of value to the humanities that are currently inaccessible or available in inadequate editions. 
These grants support full-time or part-time activities for periods of one to three years. Projects must be undertaken by a 
team of at least one editor or translator and one other staff member. Grants typically support editions and translations of 
significant literary, philosophical, and historical materials, but other types of work, such as musical notation, are also 
eligible. Applicants should demonstrate familiarity with the best practices recommended by the Association for 
Documentary Editing or the Modern Language Association Committee on Scholarly Editions. Translation projects should 
also explain the approach adopted for the particular work to be translated. Editions and translations produced with NEH 
support contain scholarly and critical apparatus appropriate to the subject matter and format of the edition. This usually 
means introductions and annotations that provide essential information about the form, transmission, and historical and 
intellectual context of the texts and documents involved. Proposals for editions of foreign language materials in the 
original language are eligible for funding, as well as proposals for editions of translated materials.  
http://www.grants.gov/web/grants/search-grants.html  
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National Digital Newspaper Program  
Funding Opportunity Number:   20140115-PJ  
Application Deadline: Jan 15, 2014  
Description: NEH is soliciting proposals from institutions to participate in the National Digital Newspaper Program 
(NDNP). NDNP is creating a national digital resource of historically significant newspapers published between 1836 and 
1922, from all the states and U.S. territories. This searchable database will be permanently maintained at the Library of 
Congress (LC) and will be freely accessible via the Internet. (See the website, Chronicling America: Historic American 
Newspapers.) An accompanying national newspaper directory of bibliographic and holdings information on the website 
directs users to newspaper titles available in all types of formats. During the course of its partnership with NEH, LC will 
also digitize and contribute to the NDNP database a significant number of newspaper pages drawn from its own 
collections. NEH intends to support projects in all states and U.S. territories, provided that sufficient funds allocated for 
this purpose are available. One organization within each U.S. state or territory will receive an award to collaborate with 
relevant state partners in this effort. Previously funded projects will be eligible to receive supplements for continued work, 
but the program will give priority to new projects. In particular, the program will give priority to projects from states and 
territories that have not received NDNP funding.  
http://www.grants.gov/web/grants/search-grants.html  
National Institutes of  Health  
Human Islet Research Network Coordinating Center (U01)  
Funding Opportunity Number: RFA-DK-13-013  
Application Receipt Date(s): February 27, 2014  
Description: This Funding Opportunity Announcement will provide support for a Coordinating Center that will provide 
the administrative infrastructure for the NIDDK funded Human Islet Research Network (HIRN).   
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-013.html  
 
Human Islet Research Network Bioinformatics Center (U01)  
Funding Opportunity Number:  RFA-DK-13-014  
Application Receipt Date(s): February 27, 2014  
Description: This Funding Opportunity Announcement (FOA) will provide support for a Bioinformatics Center that will 
provide the expertise and infrastructure needed to enhance sharing and utility of data and resources to be produced by the 
NIDDK-funded Human Islet Research Network.  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-014.html  
 
Consortium on Targeting And Regeneration (CTAR) - HIRN (UC4)  
Funding Opportunity Number: RFA-DK-13-015  
Application Receipt Date(s): February 27, 2014  
Description: This Funding Opportunity Announcement (FOA) requests applications for a new research consortium, the 
Consortium on Targeting and Regeneration (CTAR), that will support the development of innovative strategies to increase 
functional human beta cell mass in vivo through the controlled manipulation of beta cell replication or islet plasticity, or 
the reprogramming of adult non-beta cells into beta-like cells. CTAR will be part of the Human Islet Research Network 
(HIRN). http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-015.html  
 
Consortium on Human Islet Biomimetics (CHIB) - HIRN (UC4)  
Funding Opportunity Number:  RFA-DK-13-016  
Application Receipt Date(s): February 27, 2014  
Description: This FOA invites new applications to participate in the Consortium on Human Islet Biomimetics (CHIB) 
that will support the development of a human islet microphysiological system or niche (a system that combines cells, 
cytoarchitecture, matrix, physical factors, secreted factors, etc.). CHIB will be part of the Human Islet Research Network 
(HIRN).  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-016.html  
 
Consortium on Modeling Autoimmune Interactions (CMAI) - HIRN (UC4)  
Funding Opportunity Number:  RFA-DK-13-017  
Application Receipt Date(s): February 27, 2014  
Description: This Funding Opportunity Announcement (FOA) invites new applications to participate in a Consortium on 
Modeling Autoimmune Interactions (CMAI) that will be focused on the goal of developing robust systems to measure and 
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model the biology of human type 1 diabetes. CMAI will be a founding consortium within the Human Islet Research 
Network (HIRN).  Please limit this field to a brief description of ¼ to ½ page in length.  Brevity is appreciated.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-017.html  
 
Consortium on Beta-cell Death and Survival (CBDS) - HIRN (UC4)  
Funding Opportunity Number:  RFA-DK-13-018  
Application Receipt Date(s): February 27, 2014  
Description: This Funding Opportunity Announcement (FOA) requests applications for a new research consortium, the 
Consortium on Beta cell Death and Survival (CBDS). The mission of CBDS will be to better define and detect the 
mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of 
protecting the residual beta cell mass in T1D patients as early as possible in the disease process. CBDS will be part of the 
Human Islet Research Network (HIRN). http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-018.html  
 
Cigarette Tobacco Reference Products Program (UC2)  
Funding Opportunity Number:  RFA-FD-14-001  
Application Receipt Date(s): November 15, 2013  
Description: FDA's CTP is seeking to develop a cigarette tobacco reference products program that will require significant 
collaboration and research efforts with outside organizations. The selected organization(s) will develop tobacco reference 
products representing American blended cigarettes to be used for investigational non-clinical purposes by tobacco 
manufacturers, contract and government laboratories, and academic institutions. http://grants.nih.gov/grants/guide/rfa-
files/RFA-FD-14-001.html  
 
Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science (U54)  
Funding Opportunity Number:  RFA-OD-13-117  
Application Receipt Date(s): December 10, 2013  
Description: This Funding Opportunity Announcement (FOA) invites applications for a Center for Evaluation and 
Coordination of Training and Research (CECTR) in Tobacco Regulatory Science. The CECTR will become a national 
resource in tobacco regulatory science, will support and conduct an evaluation of the scientific programs funded by the 
Food and Drug Administration (FDA) Center for Tobacco Products (CTP), and will facilitate coordination and 
communications of research and scientific training within those programs. The overall objective of the CECTR is to 
evaluate and support training and research programs that can inform the FDA CTP in the development and evaluation of 
tobacco product regulatory activities and actions.  Through leadership, evaluation, coordination, and facilitation of 
collaborative efforts, the CECTR can accelerate the advancement of science relevant to the Family Smoking Prevention 
and Tobacco Control Act (FSPTCA).  The NIH and the FDA have formed an interagency partnership to foster research 
relevant to FDA's tobacco regulatory authorities. The award under this FOA will be administered by NIH using 
designated funds from the FDA CTP for tobacco regulatory science mandated by the Family Smoking Prevention and 
Tobacco Control Act (FSPTCA), Public Law 111-31. http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-13-117.html  
 
Nutrition and Alcohol-Related Health Outcomes (R01)  
Funding Opportunity Number:  PA-13-359  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This Funding Opportunity Announcement (FOA) encourages applications that propose to examine 
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this FOA is 
to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of 
alcohol-related health outcomes including alcohol use disorder and chronic disease. http://grants.nih.gov/grants/guide/pa-
files/PA-13-359.html  
 
Nutrition and Alcohol-Related Health Outcomes (R03)  
Funding Opportunity Number:  PA-13-360  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This Funding Opportunity Announcement (FOA) encourages applications that propose to examine 
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this 
FOA  is to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a 
variety of alcohol-related health outcomes including alcohol use disorder and chronic disease.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-360.html  
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Nutrition and Alcohol-Related Health Outcomes (R21)  
Funding Opportunity Number:  PA-13-361  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description:  This Funding Opportunity Announcement (FOA) encourages applications that propose to examine 
associations between nutrition and alcohol-related health outcomes in humans and animal models. The goal of this FOA is 
to stimulate a broad range of research on the role of nutrition in the development, prevention, and treatment of a variety of 
alcohol-related health outcomes including alcohol use disorder and chronic disease.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-361.html  
 
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm 
Violence (R01)  
Funding Opportunity Number:  PA-13-363  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and 
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational 
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on 
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement 
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned 
above, particular consideration will be given to applications that propose studies of the intersection that focus on the 
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-363.html  
 
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm 
Violence (R03)  
Funding Opportunity Number:  PA-13-368  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and 
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational 
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on 
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement 
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned 
above, particular consideration will be given to applications that propose studies of the intersection that focus on the 
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-368.html  
 
Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm 
Violence (R21)  
Funding Opportunity Number:  PA-13-369  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This funding opportunity announcement (FOA) spans across the missions of several NIH Institutes and 
Centers (ICs) and Offices, and includes basic neuroscience and basic behavioral research, clinical and translational 
studies, intervention development at the individual, family and community level, efficacy trials of interventions based on 
evidence from basic and translational studies, and research to identify the best ways to disseminate and implement 
efficacious and evidence-based interventions in real-world settings. While this FOA covers all of the areas mentioned 
above, particular consideration will be given to applications that propose studies of the intersection that focus on the 
various types of violence (homicide, suicide, youth and gang-related, intimate partner) and firearms.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-369.html  
 
Neurological Sciences Academic Development Award (K12)  
Funding Opportunity Number:  PAR-13-362  
Application Receipt/Submission Date(s): December 11, 2013, October 12, 2014, October 12, 2015  
Description: The purpose of the NINDS Neurological Sciences Academic Development Award (NSADA K12) is to 
facilitate and support the research career development of pediatric neurologists at educational institutions or professional 
organizations who have made a commitment to independent research careers.  The NSADA program is intended to 
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provide three consecutive years of support to individuals to provide them with the knowledge, tools and research 
experience that will enable them to transition to significant, individually-supported research.  
http://grants.nih.gov/grants/guide/pa-files/PAR-13-362.html  
 
Development of Assays for High-Throughput Screening for Use in Probe and Pre-therapeutic Discovery (R01)  
Funding Opportunity Number:  PAR-13-364  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: The participating NIH Institutes and Centers invite Research Project Grant (R01) applications to develop 
assays for high throughput screening (HTS) for use in Probe and Pre-therapeutic Discovery. Through this FOA, NIH 
wishes to stimulate research in 1) developing assays for specific biological targets and disease mechanisms relevant to the 
mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as 
probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; and 
2) establishing collaboration with screening centers that have the requisite expertise and experience needed in 
implementation of HTS assays for the discovery and development of small molecule chemical probes. This FOA seeks to 
establish a stream of scientifically and technologically outstanding assays for screening by the NIH Molecular Libraries 
Production Centers Network (MLPCN) in the Molecular Libraries Program (MLP) and other academic centers. One 
important criterion for this initiative is novelty, so applicants are therefore encouraged to avoid focusing on areas and 
approaches that have been extensively targeted in other settings. Assays should be relevant to the scope of research in at 
least one of the participating NIH Institutes.  http://grants.nih.gov/grants/guide/pa-files/PAR-13-364.html  
 
Evaluating Natural Experiments in Healthcare to Improve Diabetes Prevention and Treatment (R18)  
Funding Opportunity Number:  PAR-13-365  
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015, 
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016  
Description: The purpose of this Research Demonstration and Disseminations Projects (R18) Funding Opportunity 
Announcement (FOA) is to support research to evaluate large scale policies or programs related to healthcare delivery that 
are expected to influence diabetes prevention and care. This FOA is not intended to support the initiation and delivery of 
new policies or programs. Research support is for the evaluation of the effectiveness of healthcare programs and/or 
policies implemented independent of NIH grant funding. The goal is to support research that meaningfully informs 
clinical practice and health policy related to prevention or management of diabetes.  
http://grants.nih.gov/grants/guide/pa-files/PAR-13-365.html  
 
Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R18)  
Funding Opportunity Number:  PAR-13-366  
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015, 
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016  
Description: The purpose of this Research Demonstration and Dissemination Projects (R18) Funding Opportunity 
Announcement (FOA) is to support research to test approaches to improve diabetes treatment and prevention in existing 
healthcare settings. Applications are sought that test practical and potentially sustainable strategies, delivered in routine 
clinical care settings, to improve processes of care and health outcomes of individuals who are at risk for or have diabetes. 
The goal is that the research results will improve routine clinical practice and inform policy in representative healthcare 
settings.  http://grants.nih.gov/grants/guide/pa-files/PAR-13-366.html  
 
Planning Grants for Pragmatic Research in Healthcare Settings to Improve Diabetes Prevention and Care (R34)  
Funding Opportunity Number:  PAR-13-367  
Application Receipt/Submission Date(s): March 3, 2014, July 1, 2014, November 3, 2014, March 2, 2015 , July 1, 2015, 
November 2, 2015, March 1, 2016, July 1, 2016, and November 1, 2016  
Description: The purpose of this Planning Grant (R34) is to support research to develop and pilot test approaches to 
improve diabetes treatment and prevention in existing healthcare settings. Applications should pilot test practical and 
potentially sustainable strategies, delivered in routine clinical care settings, to improve processes of care and health 
outcomes of individuals who are at risk for or have diabetes. The goal is that, if the pilot study shows promise, the data 
from the R34 will be used to support a full scale trial that could improve routine clinical practice and inform policy in 
representative healthcare settings.  http://grants.nih.gov/grants/guide/pa-files/PAR-13-367.html 
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Research Answers to NCIs Provocative Questions - Group A (R01)  
Funding Opportunity Number:   RFA-CA-13-016  
Application Receipt Date(s): January 15, 2014, and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention.  Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances.  In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Initiative involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 
FOAs and five R21 FOAs.  PQs in each Group are thematically related. However, the order of the groups and numbering 
of questions within a group are essentially arbitrary and should not be construed to indicate any order of priority.  This 
FOA using the R01 funding mechanism solicits applications for PQs in Group A. The companion FOA for PQs in Group 
A, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-017. PQs in this group challenge 
investigators to seek answers to specific unsolved problems generally related to investigation of changes in behavior and 
various exposure risks, mechanistic links between cancer risk factors and biological events associated with cancer 
development, and how we might identify and better understand prevention mechanisms.  Each research project proposed 
in response to this FOA must be focused on addressing one particular research problem defined by one specific PQ 
selected from the list in Group A. Projects proposed to address specific PQs may use strategies that incorporate ideas 
and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve 
the scientific focus of the specific PQ chosen.  The other four groups of PQs (and their respective FOAs) are:  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-016.html 
 
Research Answers to NCI's Provocative Questions - Group A (R21)  
Funding Opportunity Number:   RFA-CA-13-017  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention.  Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances.  In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Program involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs.  PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-017), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group 
A. The companion FOA for PQs in Group A, using the R01 funding mechanism, is RFA-CA-13-016. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to investigation of changes in 
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behavior and various exposure risks, mechanistic links between cancer risk factors and biological events associated with 
cancer development, and how we might identify and better understand prevention mechanisms.  Each research project 
proposed in response to this FOA must be focused on addressing one particular research problem defined by one specific 
PQ selected from the list in Group A. Projects proposed to address specific PQs may use strategies that incorporate ideas 
and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve 
the scientific focus of the specific PQ chosen.  The other four groups of PQs (and their respective FOAs) are:  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness. 
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-017.html 
  
Research Answers to NCIs Provocative Questions - Group B (R01)  
Funding Opportunity Number:   RFA-CA-13-018  
Application Receipt Date(s): January 15, 2014, and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention.  Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances.  In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms. The current reissuance of the PQ Initiative involves an updated set of 20 PQs. In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs.  PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority.  This FOA 
(RFA-CA-13-018), using the R01 funding mechanism, solicits applications for PQs in Group B. The companion FOA for 
PQs in Group B, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-019. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to mechanisms of tumor 
development or recurrence. Each research project proposed in response to this FOA must be focused on solving one 
particular research problem defined by one specific PQ selected from the list in Group B. Projects proposed to address 
specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. 
Transdisciplinary projects are encouraged as long as they serve the scientific focus of the specific PQ chosen.  The other 
four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness. 
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-018.html  
 
Research Answers to NCIs Provocative Questions - Group B (R21)  
Funding Opportunity Number:   RFA-CA-13-019  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
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initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing, respectively, the R01 and R21 
funding mechanisms.  The current reissuance of the PQ Program involves an updated set of 20 PQs.  In order to facilitate 
the peer review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 
FOAs and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering 
of questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This 
FOA, using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group B. The 
companion FOA for PQs in Group B, using the R01 funding mechanism, is RFA-CA-13-018. PQs in this group challenge 
investigators to seek answers to specific unsolved problems generally related to mechanisms of tumor development or 
recurrence.  Each research project proposed in response to this FOA must be focused on solving one particular research 
problem defined by one specific PQ selected from the list in Group B. Projects proposed to address specific PQs may use 
strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are 
encouraged as long as they serve the scientific focus of the specific PQ chosen. The other four groups of PQs (and their 
respective FOAs) are: 
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-019.html  
 
Research Answers to NCIs Provocative Questions - Group C (R01)  
Funding Opportunity Number:   RFA-CA-13-020  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Initiative involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-020), using the R01 funding mechanism, solicits applications for PQs in Group C. The companion FOA for 
PQs in Group C, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-021. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to the development or refinement 
of methods to detect or diagnose tumors and highlight our still nascent knowledge of the stages of tumor development as 
they relate to determining which tumors are most likely to lead to more aggressive states. Each research project proposed 
in response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected 
from the list in Group C. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
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 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and 
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-020.html  
 
Research Answers to NCIs Provocative Questions - Group C (R21)  
Funding Opportunity Number:  RFA-CA-13-021  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Program involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-021), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group 
C. The companion FOA for PQs in Group C, using the R01 funding mechanism, is RFA-CA-13-020. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to the development or refinement 
of methods to detect or diagnose tumors and highlight our still nascent knowledge of the stages of tumor development as 
they relate to determining which tumors are most likely to lead to more aggressive states. Each research project proposed 
in response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected 
from the list in Group C. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy; and 
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-021.html  
 
Research Answers to NCIs Provocative Questions - Group D (R01)  
Funding Opportunity Number:   RFA-CA-13-022  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
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gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Initiative involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-022), using the R01 funding mechanism, solicits applications for PQs in Group D. The companion FOA for 
PQs in Group D, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-023. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to the development and use of new 
therapeutic agents and how we can learn from both the successes and failures of clinical treatment. Each research project 
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ 
selected from the list in Group D. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness. 
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-022.html  
 
Research Answers to NCIs Provocative Questions - Group D (R21)  
Funding Opportunity Number:   RFA-CA-13-023  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description:  The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Program involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-023), using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group 
D. The companion FOA for PQs in Group D, using the R01 funding mechanism, is RFA-CA-13-022. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to the development and use of new 
therapeutic agents and how we can learn from both the successes and failures of clinical treatment. Each research project 
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ 
selected from the list in Group D. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
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 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis; and  
 Group E covered by RFA-CA-13-024 (R01) and RFA-CA-13-025 (R21) that generally relates to clinical 
effectiveness.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-023.html  
 
Research Answers to NCIs Provocative Questions - Group E (R01)  
Funding Opportunity Number:   RFA-CA-13-024  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Initiative involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
(RFA-CA-13-024), using the R01 funding mechanism, solicits applications for PQs in Group E. The companion FOA for 
PQs in Group E, using the R21 exploratory/developmental funding mechanism, is RFA-CA-13-025. PQs in this group 
challenge investigators to seek answers to specific unsolved problems generally related to the development of methods to 
optimize the application of cancer treatments or interventions for enhanced clinical effectiveness. Each research project 
proposed in response to this FOA must be focused on solving one particular research problem defined by one specific PQ 
selected from the list in Group E. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis; and  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy. 
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-024.html  
   
Research Answers to NCIs Provocative Questions - Group E (R21)  
Funding Opportunity Number:   RFA-CA-13-025  
Application Receipt Date(s): January 15, 2014 and June 20, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support innovative research projects 
designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions 
initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's 
priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific 
problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of 
these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been 
adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important 
gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but 
that now may be open to investigations using new strategies and recent technical advances. In the second issuance in 
2012, there were eight PQs FOAs, each covering a subset of identified PQs and utilizing the R01 and R21 funding 
mechanisms.  The current reissuance of the PQ Program involves an updated set of 20 PQs.  In order to facilitate the peer 
review process, the new/updated PQs have been divided into five groups related by themes resulting in five R01 FOAs 
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and five R21 FOAs. PQs in each Group are thematically related. However, the order of the groups and numbering of 
questions within a group are essentially arbitrary and should not be construed to indicate any order of priority. This FOA 
using the R21 exploratory/developmental funding mechanism, solicits applications for PQs in Group E. The companion 
FOA for PQs in Group E, using the R01 funding mechanism, is RFA-CA-13-024. PQs in this group challenge 
investigators to seek answers to specific unsolved problems generally related to the development of methods to optimize 
the application of cancer treatments or interventions for enhanced clinical effectiveness. Each research project proposed in 
response to this FOA must be focused on solving one particular research problem defined by one specific PQ selected 
from the list in Group E. Projects proposed to address specific PQs may use strategies that incorporate ideas and 
approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the 
scientific focus of the specific PQ chosen. The other four groups of PQs (and their respective FOAs) are:  
 Group A covered by RFA-CA-13-016 (R01) and RFA-CA-13-017 (R21) that generally relates to cancer prevention 
and risk;  
 Group B covered by RFA-CA-13-018 (R01) and RFA-CA-13-019 (R21) that generally relates to mechanisms of 
tumor development or recurrence;  
 Group C covered by RFA-CA-13-020 (R01) and RFA-CA-13-021 (R21) that generally relates to cancer detection, 
diagnosis, and prognosis; and  
 Group D covered by RFA-CA-13-022 (R01) and RFA-CA-13-023 (R21) that generally relates to cancer therapy.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-025.html  
 
Interpreting Variation in Human Non-Coding Genomic Regions Using Computational Approaches and 
Experimental Assessment (R01)  
Funding Opportunity Number:   RFA-HG-13-013  
Application Receipt Date(s): January 21, 2014 and January 21, 2015  
Description:  This Funding Opportunity Announcement (FOA) solicits applications to develop highly innovative 
computational approaches for interpreting sequence variants in the non-protein-coding regions of the human genome.  The 
goal is to develop methods that analyze whole-genome sequence data by integrating data sets, such as ones on genome 
function, phenotypes, patterns of variation, and other features, to identify or substantially narrow the set of variants that 
are candidates for affecting organismal function leading to disease risk or other traits.  The accuracy of the computational 
approaches developed should be assessed using experimental data.  http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-
13-013.html  
 
Patient-Centered Outcomes Research (PCOR) for Treatment Options in Uterine Fibroids: Developing a 
Prospective Multi-Center Practice-based Clinical Registry (P50)  
Funding Opportunity Number:   RFA-HS-14-006  
Application Receipt Date(s): December 16, 2013  
Description: The Agency for Healthcare Research and Quality (AHRQ), in partnership with the Patient-Centered 
Outcomes Research Institute (PCORI), invites applications for funding to examine the relative effectiveness of treatment 
options for women of childbearing age with uterine fibroids. For women with symptomatic uterine fibroids, it is unclear 
which treatment strategies are more effective in managing symptoms and addressing patient preferences for reproductive 
options. As a result, patients and their clinicians often must decide on a plan of action without guidance from strong 
scientific evidence. Due to the complexity of treatment options, high quality evidence can help women select specific 
treatment options tailored to their individual preferences. AHRQ and PCORI intend to fund one application that will 
include a registry Research and Data Coordinating Center (RDCC) to build a registry infrastructure that involves six to ten 
separate and geographically diverse clinical centers (CC). http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-14-
006.html  
 
NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24)  
Funding Opportunity Number:  PAR-13-370  
Application Receipt Date(s): January 28, 2014, January 28, 2015, and January 28, 2016  
Description: The National Eye Institute (NEI) announces the reissue of PAR-10-281, "Translational Research Program 
(TRP) on Therapy for Visual Disorders".  This program focuses on the development of novel therapies to treat visual 
diseases and disorders.  In the context of this program, an expert develops a multi-disciplinary research team that applies 
an integrative approach to develop rapid and efficient translation of innovative laboratory research findings into clinical 
therapeutic development. It involves collaborative teams of scientists and clinicians with expertise in multiple disciplines, 
operating according to a clear leadership plan. Such a collaborative approach is particularly appropriate for research 
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focused on pathways that will likely be targeted by biological intervention, such as gene therapy, cell-based therapy, and 
pharmacological approaches. The intention of this program is to make resources available to scientists from several 
disciplines to address scientific and technical questions that would be beyond the capabilities of any one research 
group.  Each project should have a well-defined end-point, achievable within a five-year time frame, of developing a 
specific treatment for a specific ocular disease.  The steps towards this goal should be clearly delineated in a series of 
milestones that support the development of a therapeutic, which can then be tested in a clinical trial. Highest 
programmatic priority will be given to applications aligned with NEI's audacious goal initiative 
(http://nei.nih.gov/audacious/).  If successful, a project funded under this program could lead to filing an IND and a 
subsequent application for an NEI U10 Clinical Vision Research Grant or an R34 Clinical Study Development Grant.  
http://grants.nih.gov/grants/guide/pa-files/PAR-13-370.html 
 
Planning for a National Center for Particle Beam Radiation Therapy Research (P20)  
Funding Opportunity Number: (PAR-13-371)  
Application Receipt/Submission Date(s): January 21, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage and support planning 
efforts for establishing a Center for Particle Beam Radiation Therapy (PBRT) Research. The Center must be planned to 
operate as a research center adjunct to an independently created and funded, sustainable clinical facility for PBRT. 
Ultimately, the proposed Center is expected to perform clinically relevant research using proton and heavier ion beams 
(including but not necessarily limited to carbon beams). The goal of this FOA is to provide the awardees with funding to 
enable inclusion of necessary resources (expertise or facilities) to carry out basic, and translational, and clinical research 
complementary to a clinical PBRT facility. The necessary expertise and efforts would be provided by a multidisciplinary 
team of basic, translational, and clinical researchers, including physicists, engineers, biologists, and physicians, while the 
research facilities may include, by way of example, cell culture laboratories, vivarium, and clinical anesthesia units for 
pediatric patients. Applicants responding to this FOA must propose at least one pilot project that will enable a PBRT 
research agenda in particle beam delivery systems, dosimetry, radiation biology, or translational pre-clinical studies. It is 
expected that this effort will lead to a national research resource capable of successfully competing for and securing the 
funding required to operate a specialized research center for clinical PBRT. This FOA is designed to support solely the 
planning for a Research Center at a separately funded PBRT facility, and not the PBRT facility itself.  
http://grants.nih.gov/grants/guide/pa-files/PAR-13-371.html  
 
Modeling Social Behavior (R01)  
Funding Opportunity Number:  (PAR-13-374)  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This Funding Opportunity Announcement (FOA) encourages applications for developing and testing 
innovative theories and computational, mathematical, or engineering approaches to deepen our understanding of complex 
social behavior. This research will examine phenomena at multiple scales to address the emergence of collective 
behaviors that arise from individual elements or parts of a system working together. Emergence can also describe the 
functioning of a system within the context of its environment. Often properties we associate with a system itself are in 
actuality properties of the relationships and interactions between a system and its environment. This FOA will support 
research that explores the often complex and dynamic relationships among the parts of a system and between the system 
and its environment in order to understand the system as a whole. To accomplish the goals of this initiative, we encourage 
applications that build transdisciplinary teams of scientists spanning a broad range of expertise. Minimally this team 
should include investigators with expertise in the behavioral or social sciences as well as in computational and systems 
modeling (computer science, mathematics, engineering, or other systems sciences). Applications should demonstrate 
bridge-building between disciplines, scales and levels. http://grants.nih.gov/grants/guide/pa-files/PAR-13-374.html  
 
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01)  
Funding Opportunity Number:  (PAR-13-375)  
Application Receipt/Submission Date(s): March 20, 2014; March 19, 2015; March 22, 2016  
Description: The main objective of this Funding Opportunity Announcement (FOA) is to promote application of 
nutrigenetics and/or nutrigenomics approaches to nutrition research through collaborative interaction among nutrition 
researchers and experts in omics technologies. http://grants.nih.gov/grants/guide/pa-files/PAR-13-375.html  
 
NIBIB Biomedical Technology Resource Centers (P41)  
Funding Opportunity Number:   (PAR-13-376)  
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Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This Funding Opportunity Announcement (FOA) encourages grant applications for Biomedical Technology 
Resource Centers (BTRCs) that are funded using the P41 mechanism. BTRCs conduct research and development on new 
technologies that are driven by the needs of basic, translational, and clinical researchers. BTRCs also make their 
technologies available, train members of the research community in the use of the technologies, and disseminate these 
technologies broadly. http://grants.nih.gov/grants/guide/pa-files/PAR-13-376.html 
 
Secondary Analyses of Social and Behavioral Datasets in Aging (R03)  
Funding Opportunity Number:   (RFA-AG-14-008)  
Application Receipt Date(s): February 03, 2014  
Description: The purpose of this FOA is to solicit R03 applications for up to two years for secondary analysis of data on 
aging in the areas of psychology, social epidemiology, economics, sociology, and demography.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-14-008.html  
 
Pilot Clinical Trials to Eliminate the Latent HIV Reservoir (U01)  
Funding Opportunity Number:   (RFA-AI-13-055)  
Application Receipt Date(s): March 07, 2014  
Description: This Funding Opportunity Announcement (FOA) solicits applications for support of pilot clinical trials to 
evaluate interventions aimed at the elimination of the HIV reservoir in HIV-infected adults who are on suppressive 
antiretroviral therapy.  It is expected that the trials will be fully integrated with laboratory-based analytical tools to detect 
and measure elimination of latently-infected cells both in blood and in tissue.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-055.html  
 
Sub-Saharan African Collaborative HIV and Cancer Consortia (U54)  
Funding Opportunity Number:   (RFA-CA-13-010)  
Application Receipt Date(s): January 17, 2014  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to promote and facilitate research on 
HIV and cancer in Africa through collaborative efforts between investigators in United States (U.S.) and investigators in 
sub-Saharan African countries. The FOA solicits applications for Specialized Center Cooperative Agreements (U54) for 
research on HIV-associated cancers from research institutions in the U.S. and sub-Saharan Africa.  Each application is 
required to propose between two to four research projects that address high-priority questions relevant to the African 
country.  The proposed projects may range, as appropriate, from basic research to translational efforts as well as 
population and implementation studies. Clinical trials, however, will not be supported.  In addition, the proposed 
Consortium must include two mandatory cores; an Administrative/Coordinating Core and a Mentoring/Career 
Development Core.  Additional cores such as any technical shared resources cores may be included as appropriate for the 
needs of the projects.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-13-010.html  
 
Novel Methods for Detection and Measurement of Organ Fibrosis in Kidney, Bone Marrow and Urological 
Diseases (U01)  
Funding Opportunity Number:   (RFA-DK-13-026)  
Application Receipt Date(s): March 19, 2014  
Description: The purpose of this FOA is to establish a consortium to carry out research on novel methods for detection 
and measurement of organ fibrosis after acute or chronic injury in kidney, bone marrow, prostate, or urinary tract.   
http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-13-026.html  
 
Clinical Research in the Prevention, Diagnosis, and Treatment of HIV-Related Heart, Lung, and Blood (HLB) 
Diseases in Adults and Children (R01)  
Funding Opportunity Number:   (RFA-HL-14-023)  
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015  
Description: This Funding Opportunity Announcement (FOA) invites clinical research project grant (R01) applications 
on the prevention, diagnosis, and treatment of HIV-related heart, lung, and/or blood (HLB) diseases in adults and 
children. Proposed projects may utilize various approaches such as observational studies; quasi-experimental designs; and 
single-center, pilot trials. Whenever possible, investigators are strongly encouraged to leverage existing infrastructure 
such as clinical cohorts, biological specimens and imaging banks. The goal of this FOA is to address major scientific gaps 
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in characterizing, preventing, diagnosing, or treating HIV-related HLB diseases and foster multi-disciplinary 
collaborations among investigators.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-023.html  
 
Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children 
(R01)  
Funding Opportunity Number:   (RFA-HL-14-024)  
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015  
Description: This Funding Opportunity Announcement (FOA) invites basic research project grant (R01) applications to 
investigate the fundamental mechanisms underlying the pathogenesis of HIV-related heart, lung, and/or blood (HLB) 
diseases alone and in the context of antiretroviral therapy (ART). Investigations may be conducted on various primary cell 
types, biospecimens, computational models, and animal models, particularly those used for HIV research. The goal is to 
provide the critical basic science foundation and guide the design of new therapeutic approaches for HIV-related HLB 
conditions in adults and children.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-024.html  
 
Basic Research in the Pathogenesis of HIV-Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children 
(R21)  
Funding Opportunity Number:   (RFA-HL-14-029)  
Application Receipt Date(s): January 8, 2014; May 8, 2014; September 9, 2014; and January 8, 2015  
Description: This Funding Opportunity Announcement (FOA) invites basic research project grant (R21) applications to 
investigate the fundamental mechanisms underlying the pathogenesis of HIV-related heart, lung, and/or blood (HLB) 
diseases alone and in the context of antiretroviral therapy (ART). Investigations may be conducted on various primary cell 
types, biospecimens, computational models, and animal models, particularly those used for HIV research. The goal is to 
provide the critical basic science foundation and guide the design of new therapeutic approaches for HIV-related HLB 
conditions in adults and children.  
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-14-029.html  
 
Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) 
(U01)  
Funding Opportunity Number:   (RFA-TR-13-003)  
Application Receipt Date(s): December 19, 2013  
Description: The purpose of this Funding Opportunity Announcement (FOA) is to invite new and renewal cooperative 
agreement applications for the DMCC, which supports the RDCRN. The Network facilitates clinical research in rare 
diseases through support for 1) collaborative clinical research in rare diseases, including longitudinal studies of 
individuals with rare diseases, clinical studies and/or phase I , II and II/III  trials; 2) training of clinical investigators in 
rare diseases research; 3) pilot and demonstration projects; 4) clinical data management that incorporates novel 
approaches and technologies for data management, data mining, and data sharing across rare diseases, data types, and 
platforms; and 5) access to information related to rare diseases for basic and clinical researchers, academic and practicing 
physicians, patients, and the lay public.  The DMCC (U01) cooperative agreement application will focus on innovative 
ways to provide the infrastructure and support to the individual sites in their activities relevant to items 1-3 as well as a 
focus on issues relevant to items 4 and 5.  See companion FOA RFA-TR-13-002  
http://grants.nih.gov/grants/guide/rfa-files/RFA-TR-13-003.html  
 
Research on Malignancies in the Context of HIV/AIDS (R01)  
Funding Opportunity Number:   (PA-13-377)  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This funding opportunity announcement (FOA) encourages Research Project Grant (R01) applications from 
institutions/ organizations that propose to continue advancing our understanding of the risks, development, progression, 
diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) 
infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR encourage research in areas such as 
the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS 
defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i) 
provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific 
contributions resulting from HIV infection and its potential interaction with other pathogens for the development and 
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pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the 
HIV-infected population.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-377.html  
 
Research on Malignancies in the Context of HIV/AIDS (R21)  
Funding Opportunity Number:   (PA-13-378)  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: This funding opportunity announcement (FOA) encourages Research Project Grant (R21) applications from 
institutions/organizations that propose to continue advancing our understanding of the risks, development, progression, 
diagnosis, and treatment of malignancies observed in individuals with an underlying Human Immunodeficiency (HIV) 
infection or Acquired Immune Deficiency Syndrome (AIDS). The NCI and NIDCR encourage research in areas such as 
the study of the etiologic factors, cofactors, immunopathogenesis, diagnosis, and consequences of both non-AIDS 
defining and AIDS-defining malignancies in diverse populations. This FOA encourages research efforts that will (i) 
provide information on the clinical outcomes of such cancers in the HIV-infected population and (ii) identify specific 
contributions resulting from HIV infection and its potential interaction with other pathogens for the development and 
pathogenesis of these cancers. Ultimately, such efforts could inform screening approaches and therapies targeted to the 
HIV-infected population.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-378.html  
 
Administrative Supplements to NIH Awards for Validation Studies of Analytical Methods for Natural Products 
(Admin Supp)  
Funding Opportunity Number:   (PA-13-381)  
Application Receipt/Submission Date(s): January 31, 2014; June 30, 2014, October 31, 2014; January 31 2015; June 30 
2015; October 31, 2015  
Description: This Funding Opportunity Announcement (FOA) announces an administrative supplement program to 
provide funds to NCI- and NIDDK-supported research projects for validation studies of new analytical chemistry 
methods. These methods must have been developed or be under development by the awardees during the active parent 
grant. They must be methods used to identify and quantify constituents (bioactive and other chemical marker constituents 
and/or their metabolites, adulterants, or contaminants) in products intended for oral administration in humans or in 
biological specimens such as urine, plasma, or animal tissues. As test agents the products studied may be investigated in 
vitro or in vivo.  The products under investigation in parent grants may be dietary supplements (including vitamins or 
other bioactive compounds), foods, and other orally administered natural products or their raw source materials.  
http://grants.nih.gov/grants/guide/pa-files/PA-13-381.html  
 
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R01)  
Funding Opportunity Number:   (PAR-13-379)  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: The goal of this funding opportunity announcement is to support the development of well-founded outcome 
measures, including establishing their reliability and validity, for clinical studies of oral and craniofacial diseases and 
conditions.  http://grants.nih.gov/grants/guide/pa-files/PAR-13-379.html   
 
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R21)  
Funding Opportunity Number:   (PAR-13-380)  
Application Receipt/Submission Date(s): Multiple dates, see announcement.  
Description: The goal of this funding opportunity announcement is to support the development of well-founded outcome 
measures, including establishing their reliability and validity, for clinical studies of oral and craniofacial diseases and 
conditions.  http://grants.nih.gov/grants/guide/pa-files/PAR-13-380.html 
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Mirtha Alberto Director, Budget & Cost Analysis Mirtha.alberto@fiu.edu 
Henry Artigues Director, Research Operations & External Partnerships Henry.artigues@fiu.edu 
David Driesbach Director, Research Information Systems David.driesbach@fiu.edu 
Christopher Grayson Director, Research Integrity Christopher.grayson@fiu.edu 
Robert Gutierrez Director, Pre-Award Robert.gutierrrez@fiu.edu 
Pedro Hernández Director, Technology Management & Commercialization Pedro.hernandez7@fiu.edu 
Maureen Pelham Director, Research Development Maure.pelham@fiu.edu 
Aida Reus Director, Post-Award Aida.reus@fiu.edu 
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Veterinarian 
Horatiu.vinerean@fiu.edu 
Susan Webster Director, Training & International Research Initiatives Susan.webster@fiu.edu 
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